FDA Approves Olumiant® (baricitinib) for RA

Posted on

The U.S. Food and Drug Administration (FDA) approved Olumiant (baricitinib) on June 1, 2018. Produced by a joint venture between Eli Lilly and Company and Incyte Corporation, Olumiant is approved for the…

قالب وردپرس

READ  Right here's Your Full Astrological Forecast For February 2018

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.